TGFB1 and atherosclerosis: TGFβ1 levels have been demonstrated to be increased in experimental atherosclerosis [30], aortic aneurysmal disease [31], atherosclerotic plaques in patients with coronary hearth disease [32], and in monocytes circulating in patients with atrial fibrillation and fibrosis [33].